Effect of raloxifene on bone metabolism, lipid profile and glucose metabolism in postmenopausal women with type 2 diabetes mellitus
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000004399
- Lead Sponsor
- niversity of Occupational and Environmental Health, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
(1)history of phlebothrombosis (2) bed-ridden people (3)Anti-phospholipid antibody syndrome; (4)history of hypersensitivity to raloxifene or alfacalcidol (5)With effective drug of bone metabolism(bisphosphonates, vitaminK, estrogen, calcium, anabolic steroid, sex hormones)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of LDL-C before and after 6 months treatment
- Secondary Outcome Measures
Name Time Method